Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Wright

Showing results (171-180 of 195) with videos related to

Pageof 20
Sort By:
Journal of Clinical Lipidology|August 5, 2019
Treatment effect of alirocumab according to age group, smoking status, and hypertension: Pooled analysis from 10 randomized ODYSSEY studiesFrederick J Raal, Jaakko Tuomilehto, Andrei C Sposito, et al.
Circulation. Genomic and Precision Medicine|April 2, 2021
Role of Adenylate Cyclase 9 in the Pharmacogenomic Response to Dalcetrapib: Clinical Paradigm and Molecular Mechanisms in Precision Cardiovascular MedicineDavid Rhainds, Chris J Packard, Mathieu R Brodeur, et al.
The New England Journal of Medicine|November 7, 2012
Effects of dalcetrapib in patients with a recent acute coronary syndromeGregory G Schwartz, Anders G Olsson, Markus Abt, et al.
Medrxiv : the Preprint Server for Health Sciences|January 27, 2021
The Role of Disease Severity and Demographics in the Clinical Course of COVID-19 Patients Treated with Convalescent PlasmaTengfei Ma, Chad C Wiggins, Breanna M Kornatowski, et al.
American Heart Journal|July 2, 2019
Changes in comorbidities, diagnoses, therapies and outcomes in a contemporary cardiac intensive care unit populationJacob C Jentzer, Sean van Diepen, Gregory W Barsness, et al.
Frontiers in Medicine|February 14, 2022
The Role of Disease Severity and Demographics in the Clinical Course of COVID-19 Patients Treated With Convalescent PlasmaTengfei Ma, Chad C Wiggins, Breanna M Kornatowski, et al.
The American Journal of Cardiology|September 1, 2020
Characteristics and Long-Term Outcomes of Patients With Prior Coronary Artery Bypass Grafting Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial InfarctionShahyar Michael Gharacholou, Freddy Del-Carpio Munoz, Arashk Motiei, et al.
JAMA|May 4, 2006
Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes: a meta-analysis of randomized controlled trialsMatthias Briel, Gregory G Schwartz, Peter L Thompson, et al.
Frontiers in Medicine|June 24, 2021
Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide EvidenceStephen A Klassen, Jonathon W Senefeld, Katherine A Senese, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 2024
Estimates of actual and potential lives saved in the United States from the use of COVID-19 convalescent plasmaQuigly Dragotakes, Patrick W Johnson, Matthew R Buras, et al.
Pageof 20

Showing results (171-180 of 195) with videos related to

Sort By:
Pageof 20
Journal of Clinical Lipidology|August 5, 2019
Treatment effect of alirocumab according to age group, smoking status, and hypertension: Pooled analysis from 10 randomized ODYSSEY studiesFrederick J Raal, Jaakko Tuomilehto, Andrei C Sposito, et al.
Circulation. Genomic and Precision Medicine|April 2, 2021
Role of Adenylate Cyclase 9 in the Pharmacogenomic Response to Dalcetrapib: Clinical Paradigm and Molecular Mechanisms in Precision Cardiovascular MedicineDavid Rhainds, Chris J Packard, Mathieu R Brodeur, et al.
The New England Journal of Medicine|November 7, 2012
Effects of dalcetrapib in patients with a recent acute coronary syndromeGregory G Schwartz, Anders G Olsson, Markus Abt, et al.
Medrxiv : the Preprint Server for Health Sciences|January 27, 2021
The Role of Disease Severity and Demographics in the Clinical Course of COVID-19 Patients Treated with Convalescent PlasmaTengfei Ma, Chad C Wiggins, Breanna M Kornatowski, et al.
American Heart Journal|July 2, 2019
Changes in comorbidities, diagnoses, therapies and outcomes in a contemporary cardiac intensive care unit populationJacob C Jentzer, Sean van Diepen, Gregory W Barsness, et al.
Frontiers in Medicine|February 14, 2022
The Role of Disease Severity and Demographics in the Clinical Course of COVID-19 Patients Treated With Convalescent PlasmaTengfei Ma, Chad C Wiggins, Breanna M Kornatowski, et al.
The American Journal of Cardiology|September 1, 2020
Characteristics and Long-Term Outcomes of Patients With Prior Coronary Artery Bypass Grafting Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial InfarctionShahyar Michael Gharacholou, Freddy Del-Carpio Munoz, Arashk Motiei, et al.
JAMA|May 4, 2006
Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes: a meta-analysis of randomized controlled trialsMatthias Briel, Gregory G Schwartz, Peter L Thompson, et al.
Frontiers in Medicine|June 24, 2021
Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide EvidenceStephen A Klassen, Jonathon W Senefeld, Katherine A Senese, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 2024
Estimates of actual and potential lives saved in the United States from the use of COVID-19 convalescent plasmaQuigly Dragotakes, Patrick W Johnson, Matthew R Buras, et al.
Pageof 20